Voters pass end-of-life measure in Washington state

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 12
Volume 17
Issue 12

Washington state voters passed an initiative that allows doctors to prescribe lethal prescriptions to terminally ill patients who have six months or less to live.

Washington state voters passed an initiative that allows doctors to prescribe lethal prescriptions to terminally ill patients who have six months or less to live. Under Initiative 1000, patients must request the prescription from the physician and must self-administer the lethal medication. The measure also states that two physicians have to determine that the patient has an incurable disease that will cause death within six months. The physician must also recommend, but not require, the patient to notify next of kin.

The initiative is similar to Oregon’s Death With Dignity Act, which took eff ect in 1998. I-1000 marks the second time Washington voters decided an end-of-life measure. In 1991 residents rejected Initiative 119, which would have allowed doctors to write and administer lethal prescriptions, unlike I-1000 which only permits the prescription. Where do you stand on this issue? See page 2 and visit www.cancernetwork.com to register your vote to the question, “Do you agree with physician-assisted suicide?”

Recent Videos
Further optimizing a PROTAC that targets MDM2 may lead to human clinical trials among patients with cancer harboring p53 mutations.
As patients are nearing the end of life, different management strategies, such as opioids, may be needed to help mitigate pain or fatigue.
Kelley A. Rone, DNP, RN, AGNP-c, highlights the importance of having end-of-life discussions early in a patient’s cancer treatment course.
Patients treated with BCMA-directed immunotherapies for myeloma may experience susceptibility to severe infections following treatment.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
Related Content